● Recruiting

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

Condition: Systemic Lupus Erythematosus · Sponsor: GlaxoSmithKline

PhasePhase 4

Planned participants350

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a prospective, open-label, single arm 3-year clinical study to describe the short-term and long-term efficacy and safety of belimumab in participants with autoantibody positive early SLE with ongoing disease activity despite stable first-line SLE therapy.

This description comes directly from the study's public registry record.

Talk to the study team

US GSK Clinical Trials Call Center · 877-379-3718 · GSKClinicalSupportHD@gsk.com

EU GSK Clinical Trials Call Center · +44 (0) 20 89904466 · GSKClinicalSupportHD@gsk.com

Always discuss trial participation with your own doctor first.

Locations (114)

GSK Investigational Site	Anniston, Alabama, United States	Recruiting
GSK Investigational Site	Flagstaff, Arizona, United States	Recruiting
GSK Investigational Site	Mesa, Arizona, United States	Recruiting
GSK Investigational Site	Tucson, Arizona, United States	Recruiting
GSK Investigational Site	Covina, California, United States	Recruiting
GSK Investigational Site	Fontana, California, United States	Recruiting
GSK Investigational Site	Fullerton, California, United States	Recruiting
GSK Investigational Site	Long Beach, California, United States	Recruiting
GSK Investigational Site	Los Angeles, California, United States	Recruiting
GSK Investigational Site	Mission Hills, California, United States	Recruiting
GSK Investigational Site	San Diego, California, United States	Recruiting
GSK Investigational Site	Temecula, California, United States	Recruiting

+ 102 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06411249